Delivery Order SPE2DB22D3501-SPE2DB25FXH87
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,613.10 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (quantity: 30 count) under a firm fixed price contract. This non-competitive delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used to treat schizophrenia and...
- The Defense Logistics Agency awarded a delivery order valued at $21,377.39 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count packaging) under a firm fixed-price contract. This non-competitive, non-set-aside delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti is an atypical antipsychotic medication used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $74,612.17. This non-competitive delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $16.79K to AmerisourceBergen Drug Corp for supply of Rexulti (brexpiprazole) 1 mg tablets in a 30-count package. This firm fixed price, non-set-aside delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rexulti is a prescription antipsychotic medication used in treating major depressive disorder and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rexulti 1 mg tablets (30-count) valued at $5,894.80 under a firm fixed-price contract, with performance through August 21, 2025. This non-set-aside award was issued on August 20, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in treating schizophrenia and major depressive disorder, reflecting DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $15,368.07 to AmerisourceBergen Drug Corp for Rexulti 1 mg tablets (30-count units) on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in the treatment of psychiatric...
- The Defense Logistics Agency awarded a delivery order valued at $1,278.42 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count) on August 21, 2025, with completion scheduled for August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rexulti 1 mg tablets in a 30-count package, with a contract ceiling value of $4,260.21. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction and is scheduled for completion by August 15, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,525.49 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count packaging). This firm fixed-price, non-competitive delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,846.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery order and functions as a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXH87Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,691.11 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) under a firm fixed price contract. This non-competitive delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rexulti is an atypical antipsychotic medication used to treat schizophrenia and major depressive disorder, representing the type of specialty pharmaceutical product that supports military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As the prime vendor under this comprehensive pharmaceutical supply agreement, AmerisourceBergen maintains a portfolio encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The company's proven capability to fulfill federal procurement requirements through open competition, combined with its extensive experience as a major pharmaceutical distributor, positions it as a critical vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 9/15/25 |